Search results
GSK reports 100% response in rectal cancer study with Jemperli By Investing.com
Investing.com· 4 days agoGSK plc (LSE/NYSE: GSK) has shared updated results from a phase II study conducted in collaboration...
Red Flags for Early-Onset Colorectal Cancer Identified
Medscape· 4 days agoThe most common presenting signs and symptoms of early-onset colorectal cancer include rectal...
Colorectal cancer is rising among young adults — could this diet be to blame?
NY Post via Yahoo News· 4 days agoFiber is said to “feed” healthy gut bacteria, with experts suggesting that fruits such as oranges...
Immunotherapy drug may help 'cure' advanced colorectal cancer without surgery
MedicalNewsToday via AOL· 1 day agoGiving the immunotherapy drug pembrolizumab before surgery instead of chemotherapy may help improve ...
GSK’s Jemperli shows potential in Phase II trial for locally advanced rectal cancer
Clinical Trials Arena via Yahoo Finance· 3 days agoUK-based pharmaceutical company GSK has reported updated results from a Phase II study of Jemperli...
New bowel tumor drug helped cure cancer in 100% of cases
BGR· 3 days agoA drug called Jemperli (dostarlimab) showed impressive results in a phase 2 trial at the Memorial...
Colorectal cancer rates for certain people have nearly doubled in Michigan, mystifying experts
Detroit News· 3 days agoMaman is an example of how colorectal cancer rates are surging in people younger than age 50 in...
Immunotherapy bowel cancer drug works for 100% of patients
dpa international via Yahoo News· 4 days agoAn immunotherapy drug could spare bowel cancer patients the need for surgery after results showed it...
GLP-1 receptor agonists: Are they friends or foes in colorectal cancer?
MedicalNewsToday via AOL· 3 days agoA new study in mice suggests that blocking the GLP-1 receptor may help defend against colorectal ...
New Urine Test Could Help Identify More Aggressive Prostate Cancers
Health.com· 4 days agoResearchers may have developed a new, improved way to test for the most serious and aggressive forms...